Pharma Journalist -

Eli Lilly and Company and AC Immune SA announced that the two companies have signed a license and collaboration agreement to research and develop tau aggregation inhibitor small…
Read More...

X-Chem, Inc., a privately held biotechnology company applying its innovative drug discovery platform to the generation of novel small molecule therapeutics, announced a drug discovery…
Read More...

Black Diamond Therapeutics, a biotechnology company developing a new type of precision medicine for cancer, came out of stealth mode today with a $20 million Series A financing…
Read More...

Schrödinger and TB Alliance announced a three-year research collaboration to speed the development of next-generation tuberculosis (TB) treatments by leveraging Schrödinger’s advanced…
Read More...

InveniAI Corporation announced that it has entered a collaboration agreement with Kyowa Hakko Kirin Co., Ltd. (Kyowa Hakko Kirin) to harness the power of AI and ML for drug discovery.…
Read More...

Cambrex Corporation announced that it is investing $1 million at its High Point, NC site to fit out 1,300 sq. ft. of analytical laboratory space and plans to hire 9 chemical research…
Read More...

ExL Events is hosting the 3rd European Clinical Quality Oversight Forum on 25–26 February at the Hilton London Canary Wharf in London. As we all strive to…
Read More...

Amgen announced a novel multi-year collaboration with Magellan Rx Management, the pharmacy benefit management division of Magellan Health, that will leverage each company's capabilities…
Read More...

Vect-Horus announced the signing of a research collaboration agreement with Janssen Pharmaceuticals, Inc. one of the Janssen Pharmaceutical Companies of Johnson & Johnson. The goal…
Read More...

Alnylam Pharmaceuticals announced that it has resolved all litigation worldwide with Silence Therapeutics. The settlement allows Alnylam to avoid the costs and distraction associated…
Read More...